ABLAVAR™ (formerly named Vasovistâ„¢) is a blood pool agent for magnetic resonance angiography (MRA), which opens new medical imaging possibilities in the evaluation of aortoiliac occlusive disease (AIOD) in patients with suspected peripheral vascular disease.
ABLAVARâ„¢ binds reversibly to blood albumin, providing imaging with high spatial resolution up to 1 hour after injection, due to its high relaxivity and to the long lasting increased signal intensity of blood.
As with other contrast media: the possibility of serious or life-threatening anaphylactic or anaphylactoid reactions, including cardiovascular, respiratory and/or cutaneous manifestations, should always be considered.

WARNING:
NEPHROGENIC SYSTEMIC FIBROSIS Gadolinium-based contrast agents increase the risk for nephrogenic systemic fibrosis (NSF) in patients with acute or chronic severe renal insufficiency (glomerular filtration rate less than 30 mL/min/1.73m²), or acute renal insufficiency of any severity due to the hepato-renal syndrome or in the perioperative liver transplantation period.

See also Cardiovascular Imaging, Adverse Reaction, Molecular Imaging, and MRI Safety.

From Hitachi Medical Systems America Inc.;
the AIRIS II, an entry in the diagnostic category of open MR systems, was designed by Hitachi Medical Systems America Inc. (Twinsburg, OH, USA) and Hitachi Medical Corp. (Tokyo) and is manufactured by the Tokyo branch. A 0.3 T field-strength magnet and phased array coils deliver high image quality without the need for a tunnel-type high-field system, thereby significantly improving patient comfort not only for claustrophobic patients.

Developed by GE Lunar; the ARTOSCANâ„¢-M is designed specifically for in-office musculoskeletal imaging. ARTOSCAN-M's compact, modular design allows placing within a clinical environment, bringing MRI to the patient. Patients remain outside the magnet at all times during the examinations, enabling constant patient-technologist contact. ARTOSCAN-M requires no special RF room, magnetic shielding, special power supply or air conditioning.
The C-SCANâ„¢ (also known as Artoscan C) is developed from the ARTOSCANâ„¢ - M, with a new computer platform.

Quick Overview
Please note that there are different common names for this MRI artifact.

Aliasing is an artifact that occurs in MR images when the scanned body part is larger than field of view (FOV). As a consequence of the acquired k-space frequencies not being sampled densely enough, whereby portions of the object outside of the desired FOV get mapped to an incorrect location inside the FOV. The cyclical property of the Fourier transform fills the missing data of the right side with data from behind the FOV of the left side and vice versa. This is caused by a too small number of samples acquired in, e.g. the frequency encoding direction, therefore the spectrums will overlap, resulting in a replication of the object in the x direction.
Aliasing in the frequency direction can be eliminated by twice as fast sampling of the signal or by applying frequency specific filters to the received signal.
A similar problem occurs in the phase encoding direction, where the phases of signal-bearing tissues outside of the FOV in the y-direction are a replication of the phases that are encoded within the FOV. Phase encoding gradients are scaled for the field of view only, therefore tissues outside the FOV do not get properly phase encoded relative to their actual position and 'wraps' into the opposite side of the image.

Use a larger FOV, RFOV or 3D Volume, apply presaturation pulses to the undesired tissue, adjust the position of the FOV, or select a small coil which will only receive signal from objects inside or near the coil. The number of phase encoding steps must be increased in phase direction, unfortunately resulting in longer scan times.
When this is not possible it can be corrected by oversampling the data. Aliasing is eliminated by Oversampling in frequency direction. No Phase Wrap (Foldover Suppression) options typically correct the phase encoding by doubling the field of view, doubling the number of phase encodes (to keep resolution constant) and halving the number of averages (to keep scan time constant) then discarding the additional data and processing the image within the desired field of view (but this is more time consuming).
Tissue outside this doubled area can be folded nevertheless into the image as phase wrap. In this case combine more than 2 number of excitations / number of signal averages with foldover suppression.
See also Aliasing, Foldover Suppression, Oversampling, and Artifact Reduction - Aliasing.

From Hitachi Medical Systems America, Inc.;
the AIRIS made its debut in 1995. Hitachi followed up with the AIRIS II system, which has proven equally successfully. 'All told, Hitachi has installed more than 1,000 MRI systems in the U.S., holding more than 17 percent of the total U.S. MRI installed base, and more than half of the installed base of open MR systems,' says Antonio Garcia, Frost and Sullivan industry research analyst. Now Altaire employs a blend of innovative Hitachi features called VOSIâ„¢ technology, optimizing each sub-system's performance in concert with the other sub-systems, to give the seamless mix of high-field performance and the patient comfort, especially for claustrophobic patients, of open MR systems.